M347-0107 Screening compound: N-(2-ethoxyphenyl)-5-(4-methyl-1,3-thiazol-2-yl)-1-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-sulfonamide

M347-0107 Screening compound: N-(2-ethoxyphenyl)-5-(4-methyl-1,3-thiazol-2-yl)-1-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-sulfonamide
M347-0107 Screening compound: N-(2-ethoxyphenyl)-5-(4-methyl-1,3-thiazol-2-yl)-1-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M347-0107
N-(2-ethoxyphenyl)-5-(4-methyl-1,3-thiazol-2-yl)-1-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M347-0107

Molecular Formula

C22H26N4O4S2 (C22 H26 N4 O4 S2)

Compound Name

N-(2-ethoxyphenyl)-5-(4-methyl-1,3-thiazol-2-yl)-1-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-sulfonamide

IUPAC name

N-(2-ethoxyphenyl)-5-(4-methyl-13-thiazol-2-yl)-1-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-sulfonamide

SMILES

CCOc(cccc1)c1NS(c1cn(CC(N2CCCC2)=O)c(-c2nc(C)cs2)c1)(=O)=O

InChI

InChI=1S/C22H26N4O4S2/c1-3-30-20-9-5-4-8-18(20)24-32(28,29)17-12-19(22-23-16(2)15-31-22)26(13-17)14-21(27)25-10-6-7-11-25/h4-5,8-9,12-13,15,24H,3,6-7,10-11,14H2,1-2H3

InChI Key

OJQKOUMDSKBSNB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27537784

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.093

Distribution Coefficient, logD

3.070

Water Solubility, LogSw

-3.27

Polar Surface Area

75.182

Acid Dissociation Constant (pKa)

8.65

Base Dissociation Constant (pKb)

1.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

M347-0107 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with M347-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M347-0107?
Check Price and Availability of M347-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M347-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M347-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M347-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M347-0107 available by request